These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 22454828)

  • 1. Thalassemia Major in Adults: Short Stature, Hyperpigmentation, Inadequate Chelation, and Transfusion-Transmitted Infections are Key Features.
    Prakash A; Aggarwal R
    N Am J Med Sci; 2012 Mar; 4(3):141-4. PubMed ID: 22454828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic efficacy of different iron chelators in Egyptian children with Beta Thalassemia with iron overload.
    Hagag AA; Hamam MA; Taha OA; Hazaa SM
    Infect Disord Drug Targets; 2015; 15(2):98-105. PubMed ID: 26205801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocrinopathies in adolescents with thalassaemia major receiving oral iron chelation therapy.
    Sharma R; Seth A; Chandra J; Gohain S; Kapoor S; Singh P; Pemde H
    Paediatr Int Child Health; 2016 Feb; 36(1):22-7. PubMed ID: 25311879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short stature and truncal shortening in transfusion dependent thalassemia patients: results from a thalassemia center in Malaysia.
    Hamidah A; Rahmah R; Azmi T; Aziz J; Jamal R
    Southeast Asian J Trop Med Public Health; 2001 Sep; 32(3):625-30. PubMed ID: 11944728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does Profile of Hemoglobin Eβ-thalassemia Patients Change After Splenectomy? Experience of a Tertiary Thalassemia Care Centre in Eastern India.
    Mandal PK; Ghosh MK; Bhattacharyya M
    Indian J Hematol Blood Transfus; 2015 Dec; 31(4):446-52. PubMed ID: 26306069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of growth and puberty failure with respect to growth hormone and gonadotropins secretion in beta-thalassemia major.
    Moayeri H; Oloomi Z
    Arch Iran Med; 2006 Oct; 9(4):329-34. PubMed ID: 17061604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thalassemia.
    Cohen AR; Galanello R; Pennell DJ; Cunningham MJ; Vichinsky E
    Hematology Am Soc Hematol Educ Program; 2004; ():14-34. PubMed ID: 15561674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyroid function in major thalassemia patients: Is it related to height and chelation therapy?
    Eshragi P; Tamaddoni A; Zarifi K; Mohammadhasani A; Aminzadeh M
    Caspian J Intern Med; 2011; 2(1):189-93. PubMed ID: 24024013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of hepatitis B, C and D and human immunodeficiency virus infections in multi-transfused thalassemics.
    Amarapurkar DN; Kumar A; Vaidya S; Murti P; Bichile SK; Kalro RH; Desai HG
    Indian J Gastroenterol; 1992 Apr; 11(2):80-1. PubMed ID: 1428037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study on effectiveness of transfusion program in thalassemia major patients receiving multiple blood transfusions at a transfusion centre in Western India.
    Shah N; Mishra A; Chauhan D; Vora C; Shah NR
    Asian J Transfus Sci; 2010 Jul; 4(2):94-8. PubMed ID: 20859507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose Homeostasis and Effect of Chelation on β Cell Function in Children With β-Thalassemia Major.
    Gomber S; Dabas A; Bagmar S; Madhu SV
    J Pediatr Hematol Oncol; 2018 Jan; 40(1):56-59. PubMed ID: 29200160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood transfusion among thalassemia patients: A single Egyptian center experience.
    Ragab LA; Hamdy MM; Shaheen IA; Yassin RN
    Asian J Transfus Sci; 2013 Jan; 7(1):33-6. PubMed ID: 23559762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complications and Challenges in the Management of Iraqi Patients with β-Thalassemia Major: A Single-center Experience.
    Sadullah RK; Atroshi SD; Al-Allawi NA
    Oman Med J; 2020 Jul; 35(4):e152. PubMed ID: 32724663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management and clinical outcomes of transfusion-dependent thalassaemia major in an Australian tertiary referral clinic.
    Kidson-Gerber GL; Francis S; Lindeman R
    Med J Aust; 2008 Jan; 188(2):72-5. PubMed ID: 18205577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wrist Joint Skeletal Changes in Children With Transfusion-dependent Thalassemia.
    Dhawan P; Kanojia RK; Chandra J; Kumar A; Anand R; Gupta S
    J Pediatr Orthop; 2020 Jul; 40(6):e473-e478. PubMed ID: 32501918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Cutoff of Ferritin for Evaluation of Hypothyroidism in Patients With Thalassemia.
    Baghersalimi A; Rad AH; Koohmanaee S; Darbandi B; Mirzaee MM; Aminzadeh V; Medghalchi A; Dalili S
    J Pediatr Hematol Oncol; 2019 Oct; 41(7):515-518. PubMed ID: 31008807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined therapy with desferrioxamine and deferiprone in beta thalassemia major patients with transfusional iron overload.
    Daar S; Pathare AV
    Ann Hematol; 2006 May; 85(5):315-9. PubMed ID: 16450126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of early start of iron chelation therapy with deferiprone in young children newly diagnosed with transfusion-dependent thalassemia: A randomized controlled trial.
    Elalfy MS; Adly A; Awad H; Tarif Salam M; Berdoukas V; Tricta F
    Am J Hematol; 2018 Feb; 93(2):262-268. PubMed ID: 29119631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin resistance and beta cell function in chronically transfused patients of thalassemia major.
    Suvarna J; Ingle H; Deshmukh CT
    Indian Pediatr; 2006 May; 43(5):393-400. PubMed ID: 16735760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of deferiprone in patients with β-thalassaemia: impact of splenectomy and iron status.
    Limenta LM; Jirasomprasert T; Jittangprasert P; Wilairat P; Yamanont P; Chantharaksri U; Fucharoen S; Morales NP
    Clin Pharmacokinet; 2011 Jan; 50(1):41-50. PubMed ID: 21028920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.